RANI Rani Therapeutics Holdings Inc
Price (delayed)
$1.39
Market cap
$79.9M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.05
Enterprise value
$105.85M
Highlights
The EPS has increased by 21% YoY
The debt has declined by 12% since the previous quarter
The net income has grown by 12% YoY but it has contracted by 7% from the previous quarter
The company's equity has shrunk by 85% YoY and by 36% QoQ
The quick ratio has dropped by 77% year-on-year and by 7% since the previous quarter
Key stats
What are the main financial stats of RANI
Market
Valuations
Earnings
Shares outstanding
57.48M
Market cap
$79.9M
Enterprise value
$105.85M
Price to earnings (P/E)
N/A
Price to book (P/B)
39.98
Price to sales (P/S)
38.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
102.96
Revenue
$1.03M
Gross profit
$1.03M
Operating income
-$53.31M
Net income
-$30.02M
EBIT
-$24.99M
EBITDA
-$22.15M
Free cash flow
-$35.76M
Per share
Balance sheet
Liquidity
EPS
-$1.05
EPS diluted
-$1.05
Free cash flow per share
-$1.26
Book value per share
$0.03
Revenue per share
$0.04
TBVPS
$1.29
Total assets
$36.63M
Total liabilities
$33.14M
Debt
$29.71M
Equity
$1.99M
Working capital
$9.85M
Debt to equity
14.91
Current ratio
1.5
Quick ratio
1.39
Net debt/EBITDA
-1.17
Margins
Efficiency
Dividend
EBITDA margin
-2,154.5%
Gross margin
100%
Net margin
-2,920%
Operating margin
-5,186.2%
Return on assets
-67.7%
Return on equity
-782.5%
Return on invested capital
-45%
Return on capital employed
-149.2%
Return on sales
-2,430.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RANI stock price
How has the Rani Therapeutics Holdings stock price performed over time
Intraday
13.01%
1 week
-2.8%
1 month
-9.15%
1 year
-55.73%
YTD
1.46%
QTD
10.32%
Financial performance
How have Rani Therapeutics Holdings's revenue and profit performed over time
Revenue
$1.03M
Gross profit
$1.03M
Operating income
-$53.31M
Net income
-$30.02M
Gross margin
100%
Net margin
-2,920%
The operating income has grown by 19% YoY but it has contracted by 2.9% from the previous quarter
The net income has grown by 12% YoY but it has contracted by 7% from the previous quarter
Growth
What is Rani Therapeutics Holdings's growth rate over time
Valuation
What is Rani Therapeutics Holdings stock price valuation
P/E
N/A
P/B
39.98
P/S
38.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
102.96
The EPS has increased by 21% YoY
The company's equity has shrunk by 85% YoY and by 36% QoQ
RANI's P/B is 14% below its last 4 quarters average of 41.3
Efficiency
How efficient is Rani Therapeutics Holdings business performance
Rani Therapeutics Holdings's return on equity has shrunk by 82% QoQ
The ROA has plunged by 54% YoY and by 19% from the previous quarter
RANI's ROIC is down by 42% YoY and by 24% from the previous quarter
Dividends
What is RANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RANI.
Financial health
How did Rani Therapeutics Holdings financials performed over time
Rani Therapeutics Holdings's total assets is 11% more than its total liabilities
The quick ratio has dropped by 77% year-on-year and by 7% since the previous quarter
The current ratio has shrunk by 76% YoY and by 6% QoQ
The company's equity has shrunk by 85% YoY and by 36% QoQ
The company's debt to equity rose by 38% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.